Neurophyxia B.V. is an innovative drug development
company, focusing on disorders affecting the newborn child.

The lead product, 2-Iminobiotin (2-IB) is a biotin (Vitamin H or B7) analogue and is presently in development for the treatment and prevention of the devastating effects of perinatal asphyxia (oxygen shortage at birth).

Read More »